Clinical trial
A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension
NCT00058929
Study timeline
Study start (unknown)2002-10-01Date precision: month
Registry last updated2013-03-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pulmonary Arterial Hypertensionunresolved
Pulmonary Hypertensionunresolved
Interventions
treprostinil sodiumDRUG · verified · RxNorm: treprostinil sodium
Sponsors & collaborators
United Therapeuticslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00058929 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.